Maha Othman and Marc Carrier
May 10, 2025, 06:35
Maha Othman: Pleasure to Interview the Brilliant Dr. Marc Carrier at Our Latest Thrombosis Canada Clot Conversation Podcast
Professor Maha Othman, Co-Chairman SSC on Disseminated intravascular coagulopathy at International Society on Thrombosis and Haemostasis, shared a post on X:
“Pleasure to interview the brilliant Dr. Marc Carrier at our latest Thrombosis Canada clot conversation podcast. Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose; preventing recurrent VTE in cancer patients while resulting in less bleeding.”
Quoting Thrombosis Canada‘s post:
“New study, new standard? Reduced-dose apixaban may change the game in cancer-associated thrombosis. Dr. Carrier explains why.
Listen here.”
Find more on Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia